Unknown

Dataset Information

0

Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1.


ABSTRACT: p53 is the most frequently mutated gene in human cancers and mutant p53 has a gain of function (GOF) that promotes tumor progression and therapeutic resistance. One of the major GOF activities of mutant p53 is to suppress 2 other p53 family proteins, p63 and p73. However, the molecular basis is not fully understood. Here, we examined whether mutant p53 antagonizes p63/p73-mediated tumor suppression in vivo by using mutant p53-R270H knockin and TAp63/p73-deficient mouse models. We found that knockin mutant p53-R270H shortened the life span of p73 +/- mice and subjected TAp63 +/- or p73 +/- mice to T lymphoblastic lymphomas (TLBLs). To unravel the underlying mechanism, we showed that mutant p53 formed a complex with Notch1 intracellular domain (NICD) and antagonized p63/p73-mediated repression of HES1 and ECM1. As a result, HES1 and ECM1 were overexpressed in TAp63 +/- ;p53 R270H/- and p73 +/- ;p53 R270H/- TLBLs, suggesting that normal function of HES1 and ECM1 in T cell activation is hyperactivated, leading to lymphomagenesis. Together, our data reveal a previously unappreciated mechanism by which GOF mutant p53 hijacks the p63/p73-regulated transcriptional program via the Notch1 pathway.

SUBMITTER: Zhang J 

PROVIDER: S-EPMC6883818 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1.

Zhang Jin J   Sun Wenqiang W   Kong Xiangmudong X   Zhang Yanhong Y   Yang Hee Jung HJ   Ren Cong C   Jiang Yuqian Y   Chen Mingyi M   Chen Xinbin X  

Proceedings of the National Academy of Sciences of the United States of America 20191111 48


p53 is the most frequently mutated gene in human cancers and mutant p53 has a gain of function (GOF) that promotes tumor progression and therapeutic resistance. One of the major GOF activities of mutant p53 is to suppress 2 other p53 family proteins, p63 and p73. However, the molecular basis is not fully understood. Here, we examined whether mutant p53 antagonizes p63/p73-mediated tumor suppression in vivo by using mutant p53-R270H knockin and <i>TAp63/p73</i>-deficient mouse models. We found th  ...[more]

Similar Datasets

| S-EPMC4351904 | biostudies-literature
| S-EPMC3209258 | biostudies-literature
| S-EPMC9296871 | biostudies-literature
| S-EPMC2868896 | biostudies-literature
| S-EPMC9313412 | biostudies-literature
| S-EPMC2764906 | biostudies-literature
| S-EPMC11405828 | biostudies-literature
| S-EPMC5342497 | biostudies-literature
| S-EPMC4535712 | biostudies-literature
2025-01-14 | GSE286978 | GEO